ASCO Melanoma Update, Promising Targeted Therapies

The treatment options for advanced melanoma are changing as doctors unlock the secrets of genetic subtypes and new drugs are developed. Now, more inhibitors of the BRAF gene are showing promise. As Dr. Kim Margolin explains, there is still a long way to go, but the news from the ASCO meeting is encouraging and she urges patients to consider participating in clinical trials that could benefit them and other patients to come.